Skip to main content
Fig. 2 | Journal of Translational Medicine

Fig. 2

From: Characterization of IL-19, -20, and -24 in acute and chronic kidney diseases reveals a pro-fibrotic role of IL-24

Fig. 2

The expression of Il19, Il20 and Il24 in the kidney of ischemia/reperfusion (I/R), lipopolysaccharide (LPS) or streptozotocin (STZ) induced animal models of kidney diseases. The renal mRNA expression of Il19, Il20, and Il24 of rats with I/R (a) or LPS (b) induced acute kidney disease, or that of STZ-induced diabetic rats (c) was determined by real-time RT-PCR in comparison with Gapdh as internal control. Values were expressed as mean ± SD. n = 5–6 in each group; *p < 0.05 vs. control (Mann–Whitney U-test). Scale bar: 50 µm

Back to article page